DrugPatentWatch Database Preview

Akorn Company Profile

AKORN has one hundred and sixty-eight approved drugs.

There is one US patent protecting AKORN drugs. There are three tentative approvals on AKORN drugs.

There are two patent family members on AKORN drugs in two countries and one hundred and forty-nine supplementary protection certificates in twelve countries.

International Patents:	2
US Patents:	1
Tradenames:	133
Ingredients:	122
NDAs:	168
Patent Litigation for Akorn:	See patent lawsuits for Akorn
PTAB Cases with Akorn as petitioner:	See PTAB cases with Akorn as petitioner

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Akorn	SULFACETAMIDE SODIUM	sulfacetamide sodium	SOLUTION/DROPS;OPHTHALMIC	040216-001	May 25, 1999		DISCN	No	No		➤ Sign Up				➤ Sign Up
Akorn	VORICONAZOLE	voriconazole	TABLET;ORAL	207049-002	Sep 7, 2016	AB	RX	No	No		➤ Sign Up				➤ Sign Up
Akorn Inc	APRACLONIDINE HYDROCHLORIDE	apraclonidine hydrochloride	SOLUTION/DROPS;OPHTHALMIC	077764-001	Mar 12, 2009	AT	RX	No	No		➤ Sign Up				➤ Sign Up
Akorn	AKTEN	lidocaine hydrochloride	GEL;OPHTHALMIC	022221-001	Oct 7, 2008		RX	Yes	Yes	8,759,401	➤ Sign Up	Y			➤ Sign Up
Akorn	ATROPINE SULFATE	atropine sulfate	SOLUTION/DROPS;OPHTHALMIC	206289-001	Jul 18, 2014		RX	Yes	Yes		➤ Sign Up				➤ Sign Up
Akorn	DESOXIMETASONE	desoximetasone	GEL;TOPICAL	090727-001	Mar 10, 2011	AB	RX	No	No		➤ Sign Up				➤ Sign Up
Akorn	DESOXIMETASONE	desoximetasone	CREAM;TOPICAL	203234-001	Jun 12, 2015	AB	RX	No	No		➤ Sign Up				➤ Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Akorn	ALFENTA	alfentanil hydrochloride	INJECTABLE;INJECTION	019353-001	Dec 29, 1986	4,167,574	➤ Sign Up
Akorn	SUFENTA PRESERVATIVE FREE	sufentanil citrate	INJECTABLE;INJECTION	019050-001	May 4, 1984	3,998,834	➤ Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial
Country	Document Number	Estimated Expiration
World Intellectual Property Organization (WIPO)	2008014036	➤ Sign Up
European Patent Office	2043601	➤ Sign Up
Country	Document Number	Estimated Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial
Supplementary Protection Certificate	SPC Country	SPC Expiration	SPC Description
0822	Netherlands	➤ Sign Up	PRODUCT NAME: RITUXIMAB EN RECOMBINANT HUMAAN HYALURONIDASE; REGISTRATION NO/DATE: EU/1/98/067/003 - UITVOERINGSBESLUIT C(2014)2048 20140326
/1997	Austria	➤ Sign Up	PRODUCT NAME: ATORVASTATIN CALCIUM; NAT. REGISTRATION NO/DATE: 1-21926, 1-21927, 1-21928 19970411; FIRST REGISTRATION: GB PL 00018/0240 - PL 00018/0242 19961107
462	Luxembourg	➤ Sign Up	PRODUCT NAME: BRIMONIDINE ET SES SELS PHARMACEUTIQUES POUR L UTILISATION COMME MEDICAMENT POUR LE TRAITEMENT DES ROUGEURS INDUITES PAR LA ROSACEA.FIRST REGISTRATION: 20140225
C0005	Belgium	➤ Sign Up	PRODUCT NAME: FOSPHENYTOIN DISODIUM; NAT. REGISTRATION NO/DATE: NL 23 613 19980806; FIRST REGISTRATION: GB - PL 000 19/0157 19980204
00683	Netherlands	➤ Sign Up	PRODUCT NAME: BRIMONIDINE EN FARMACEUTISCH AANVAARDBARE ZOUTEN DAARVAN VOOR TOEPASSING ALS GENEESMIDDEL VOOR DE BEHANDELING VAN DOOR ROSACEA GEINDUCEERDE ROODHEID; REGISTRATION NO/DATE: EU/1/13/904 20140225
90031-1	Sweden	➤ Sign Up	PRODUCT NAME: LATANOPROST
90064-1	Sweden	➤ Sign Up	PRODUCT NAME: SIMEPREVIR, OR A PHARMACEUTICALLY ACCEPTABLE SALT THEREOF, INCLUDING SIMEPREVIR SODIUM; REG. NO/DATE: EU/1/14/924 20140516
Supplementary Protection Certificate	SPC Country	SPC Expiration	SPC Description

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.